Cargando…
Prognostic Markers of Microinvasive Breast Carcinoma: A Systematic Review and Meta-Analysis
SIMPLE SUMMARY: Microinvasive breast carcinoma is an infiltrating carcinoma that measures ≤1 mm. The prognostic factors associated with this disease have not been extensively investigated. In this study, we aimed to perform a systematic review and meta-analysis to examine the prognostic factors of m...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252130/ https://www.ncbi.nlm.nih.gov/pubmed/37296968 http://dx.doi.org/10.3390/cancers15113007 |
_version_ | 1785056097659256832 |
---|---|
author | Ambrosini-Spaltro, Andrea Di Donato, Francesco Saragoni, Luca Cserni, Gábor Rakha, Emad Foschini, Maria Pia |
author_facet | Ambrosini-Spaltro, Andrea Di Donato, Francesco Saragoni, Luca Cserni, Gábor Rakha, Emad Foschini, Maria Pia |
author_sort | Ambrosini-Spaltro, Andrea |
collection | PubMed |
description | SIMPLE SUMMARY: Microinvasive breast carcinoma is an infiltrating carcinoma that measures ≤1 mm. The prognostic factors associated with this disease have not been extensively investigated. In this study, we aimed to perform a systematic review and meta-analysis to examine the prognostic factors of microinvasive breast carcinoma. From 618 screened records, 5 were selected. The meta-analyses found a significant association between lymph node status and prognosis. No significant prognostic impacts were found for the following factors: estrogen receptor, progesterone receptor, HER2 status, multifocality or grade of microinvasion, or patient’s age. Therefore, the data obtained demonstrate that lymph node status is a main prognostic factor of microinvasive breast carcinoma. ABSTRACT: (1) Background: The prognostic factors of microinvasive (≤1 mm) breast carcinoma are not completely clear. The aim of this study was to perform a systematic review and meta-analysis to clarify these factors. (2) Methods: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology was followed. Two databases were interrogated, PubMed and Embase, and papers in English were included to address this question. The selected studies were those that reported on female patients affected by microinvasive carcinoma, and on prognostic factors with a hazard ratio (HR) for disease-free survival (DFS) and overall survival (OS). (3) Results: In total, 618 records were identified. After removing duplicates (166), identification, and screening (336 by title and abstract alone, 116 by full text and eventual supplementary material), 5 papers were selected. Seven different meta-analyses were conducted in this study, all referring to DFS, analyzing the following prognostic factors: estrogen receptor, progesterone receptor, HER2 status, multifocality and grade of microinvasion, patient’s age, and lymph node status. Only lymph node status was associated with prognosis and DFS (total number of cases: 1528; Z = 1.94; p = 0.05). The other factors examined did not significantly affect prognosis (p > 0.05). (4) Conclusions: Positive lymph node status significantly worsens prognosis in patients with microinvasive breast carcinoma. |
format | Online Article Text |
id | pubmed-10252130 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102521302023-06-10 Prognostic Markers of Microinvasive Breast Carcinoma: A Systematic Review and Meta-Analysis Ambrosini-Spaltro, Andrea Di Donato, Francesco Saragoni, Luca Cserni, Gábor Rakha, Emad Foschini, Maria Pia Cancers (Basel) Systematic Review SIMPLE SUMMARY: Microinvasive breast carcinoma is an infiltrating carcinoma that measures ≤1 mm. The prognostic factors associated with this disease have not been extensively investigated. In this study, we aimed to perform a systematic review and meta-analysis to examine the prognostic factors of microinvasive breast carcinoma. From 618 screened records, 5 were selected. The meta-analyses found a significant association between lymph node status and prognosis. No significant prognostic impacts were found for the following factors: estrogen receptor, progesterone receptor, HER2 status, multifocality or grade of microinvasion, or patient’s age. Therefore, the data obtained demonstrate that lymph node status is a main prognostic factor of microinvasive breast carcinoma. ABSTRACT: (1) Background: The prognostic factors of microinvasive (≤1 mm) breast carcinoma are not completely clear. The aim of this study was to perform a systematic review and meta-analysis to clarify these factors. (2) Methods: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology was followed. Two databases were interrogated, PubMed and Embase, and papers in English were included to address this question. The selected studies were those that reported on female patients affected by microinvasive carcinoma, and on prognostic factors with a hazard ratio (HR) for disease-free survival (DFS) and overall survival (OS). (3) Results: In total, 618 records were identified. After removing duplicates (166), identification, and screening (336 by title and abstract alone, 116 by full text and eventual supplementary material), 5 papers were selected. Seven different meta-analyses were conducted in this study, all referring to DFS, analyzing the following prognostic factors: estrogen receptor, progesterone receptor, HER2 status, multifocality and grade of microinvasion, patient’s age, and lymph node status. Only lymph node status was associated with prognosis and DFS (total number of cases: 1528; Z = 1.94; p = 0.05). The other factors examined did not significantly affect prognosis (p > 0.05). (4) Conclusions: Positive lymph node status significantly worsens prognosis in patients with microinvasive breast carcinoma. MDPI 2023-05-31 /pmc/articles/PMC10252130/ /pubmed/37296968 http://dx.doi.org/10.3390/cancers15113007 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Systematic Review Ambrosini-Spaltro, Andrea Di Donato, Francesco Saragoni, Luca Cserni, Gábor Rakha, Emad Foschini, Maria Pia Prognostic Markers of Microinvasive Breast Carcinoma: A Systematic Review and Meta-Analysis |
title | Prognostic Markers of Microinvasive Breast Carcinoma: A Systematic Review and Meta-Analysis |
title_full | Prognostic Markers of Microinvasive Breast Carcinoma: A Systematic Review and Meta-Analysis |
title_fullStr | Prognostic Markers of Microinvasive Breast Carcinoma: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Prognostic Markers of Microinvasive Breast Carcinoma: A Systematic Review and Meta-Analysis |
title_short | Prognostic Markers of Microinvasive Breast Carcinoma: A Systematic Review and Meta-Analysis |
title_sort | prognostic markers of microinvasive breast carcinoma: a systematic review and meta-analysis |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252130/ https://www.ncbi.nlm.nih.gov/pubmed/37296968 http://dx.doi.org/10.3390/cancers15113007 |
work_keys_str_mv | AT ambrosinispaltroandrea prognosticmarkersofmicroinvasivebreastcarcinomaasystematicreviewandmetaanalysis AT didonatofrancesco prognosticmarkersofmicroinvasivebreastcarcinomaasystematicreviewandmetaanalysis AT saragoniluca prognosticmarkersofmicroinvasivebreastcarcinomaasystematicreviewandmetaanalysis AT csernigabor prognosticmarkersofmicroinvasivebreastcarcinomaasystematicreviewandmetaanalysis AT rakhaemad prognosticmarkersofmicroinvasivebreastcarcinomaasystematicreviewandmetaanalysis AT foschinimariapia prognosticmarkersofmicroinvasivebreastcarcinomaasystematicreviewandmetaanalysis |